SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hirschhorn K, Cooper HL, Firschein IL. Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1965;1: 479482.
  • 2
    Lurie IW, Lazjuk GI, Ussova YI, et al. The Wolf-Hirschhorn syndrome, I: genetics. Clin Genet 1980;17: 375384.
  • 3
    Wright TJ, Ricke DO, Denison K, et al. A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Genet 1997;6: 317324.DOI: 10.1093/hmg/6.2.317
  • 4
    Neu RL, Shott RJ, Gardner LI. 4p- phenotype in an infant with t (4p-; 19p or q+) mat translocation. Am J Dis Child 1975;129: 363365.
  • 5
    Kanazawa O, Irie N, Kawai I. Epileptic seizures in the 4p- syndrome: Report of two cases. Jpn J Psychiatry Neurol 1991;45: 653659.
  • 6
    Battaglia D, Zampino G, Zollino M, et al. Electroclinical patterns and evolution of epilepsy in the 4p- syndrome. Epilepsia 2003;44: 118390.
  • 7
    Battaglia A, Carey JC, Cederholm P, et al. Natural history of Wolf-Hirschhorn syndrome: experience with 15 cases. Pediatrics 1999;103: 8306.
  • 8
    Battaglia A, Carey JC, Wright TJ. Wolf-Hirschhorn (4p-) syndrome. Adv Pediatr 2001;48: 75113.
  • 9
    Sgro V, Riva E, Canevini MP, et al. 4p(-) syndrome: A chromosomal disorder associated with a particular EEG pattern. Epilepsia 1995;36: 12061214.
  • 10
    Ernst JP, Doose H, Baier WK. Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood. Brain Dev 1998;10: 385388.
  • 11
    Oguni H, Hayashi K, Oguni M, et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 1994;35: 11401145.
  • 12
    Browne TR, Ascanape JS. Diones, Paraldehyde, Phenacemide, Bromides, and Sulthiame. In: EngelJ, PedleyTA, eds. Epilepsia: a comprehensive textbook. Philadelphia : Lippincott-Raven, 1998: 163444.
  • 13
    Claes L, Del-Favero J, Ceulemans B, et al: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68: 132732.
  • 14
    Endele S, Fuhry M, Pak SJ, et al. LETM1, a novel gene encoding a putative EF-hand Ca(2+)-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics 1999;60: 218225.DOI: 10.1006/geno.1999.5881
  • 15
    Meierkord H, Grunig F, Gutschmidt U, et al. Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition. Naunyn Schmiedebergs Arch Pharmacol 2000;361: 2532.DOI: 10.1007/s002109900162